Product sales
Our complementary healthcare businesses address the changing needs of patients and societies worldwide. With innovative pharmaceuticals at the core, we are also a global leader in generics, vaccines and consumer health products.
Read more about the 2011 sales of our top 20 pharmaceutical products in the table below.
For more information, visit our products section
| Product | Full Year 2011 Product Sales | Therapeutic Area | |
|---|---|---|---|
| USD m | % change (USD) | ||
|
5,665 | -6% | Cardiovascular and Metabolism |
|
4,659 | 9% | Oncology |
|
2,050 | 34% | Neuroscience and Ophthalmics |
|
1,487 | -2% | Oncology |
|
1,443 | 12% | Oncology |
|
1,209 | 34% | Cardiovascular and Metabolism |
|
1,067 | 6% | Neuroscience and Ophthalmics |
|
911 | -34% | Oncology |
|
903 | 4% | Immunology and Infectious Diseases |
|
850 | 12% | Oncology |
|
794 (excl. OTC) | 0% | Immunology and Infectious Diseases |
|
716 | 79% | Oncology |
|
677 | 73% | Cardiovascular and Metabolism |
|
614 | 2% | Neuroscience and Ophthalmics |
|
613 | 6% | Immunology and Infectious diseases |
|
557 | 27% | Cardiovascular and Metabolism |
|
550 | 19% | Neuroscience and Ophthalmics |
|
518 | 17% | Immunology and Infectious diseases |
|
494 | nm | Neuroscience and Ophthalmics |
|
478 | 30% | Respiratory |
nm - not meaningful
